Overall rank by patents
#13,173
Across all tracked assignees
USPTO PatentsView assignee record - 23 granted patents across 12 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
Synexis holds 23 US patents across 12 technology areas, rank #13,173 of 50,000 tracked assignees.
Synexis Llc has been granted 23 US utility patents between 2017 and 2025, placing Synexis Llc at rank #13,173 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a US Corporation, Synexis Llc is one of the more focused assignees in the PatentsView dataset. By volume, Synexis sits between Study Social, Inc. (23 patents, rank #13,169) and Taewoong Medical Co., Ltd (23 patents, rank #13,177) - the closest US assignees by grant volume. The composite Innovation Score of 38.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 16 grants, compared with 7 in the 2015–2019 window, a +129% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Synexis Llc's 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Synexis Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Study Social, Inc.
23 patents
Sun Nuclear Corporation
23 patents
Sunesis Pharmaceuticals, Inc.
23 patents
Sweet Darling Sales, Inc.
23 patents
Syntiant Corp.
23 patents
Sysdig, Inc.
23 patents
TABOOLA.COM LTD.
23 patents
TAEWOONG MEDICAL CO., LTD
23 patents
Synexis LLC
23 patents
What this shows Synexis holds 23 patents at rank #13,173, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,173 in granted patent volume.
Other assignees with the most granted patents in Synexis's primary technology class.
Synexis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 4.3% |
| 2018 | 2 | 8.7% |
| 2019 | 4 | 17.4% |
| 2020 | 2 | 8.7% |
| 2021 | 3 | 13.0% |
| 2022 | 5 | 21.7% |
| 2023 | 1 | 4.3% |
| 2024 | 3 | 13.0% |
| 2025 | 2 | 8.7% |
Top 12 of 12 technology areas
Overall rank by patents
#13,173
Across all tracked assignees
38.6 out of 100
How to use this portfolio
Synexis's 23 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.